Form 4: Natera Co-Founder Jonathan Sheena Sells Shares Under 10b5-1 Trading Plans

Natera co-founder Jonathan Sheena sold a significant number of shares on November 13, 2024, under pre-arranged 10b5-1 trading plans.

Summary

• Jonathan Sheena, a co-founder of Natera, Inc., executed multiple sales of common stock on November 13, 2024.
• These sales were conducted under two separate Rule 10b5-1 trading plans adopted on December 12, 2023, and June 7, 2024.
• A total of 27,765 shares were sold directly by Sheena at weighted average prices ranging from $152.69 to $160.02.
• Additionally, 16,220 shares held indirectly through the Caraluna 1 and Caraluna 2 Trusts were sold at weighted average prices ranging from $152.78 to $160.02.
• Following these transactions, Sheena directly owns 259,772 shares and indirectly owns 199,735 shares through the trusts.

Sentiment

Score: 4

Explanation: The document details insider selling, which is generally viewed with caution by investors. However, the sales were pre-planned under 10b5-1 plans, which mitigates some of the negative sentiment.

Risks

• The sales by a co-founder could be perceived negatively by the market, potentially impacting investor confidence.
• The use of 10b5-1 plans indicates pre-planned sales, but the volume of shares sold could still raise concerns.

Industry Context

Insider sales are a common occurrence, but the volume and the fact that it's a co-founder selling may draw attention in the biotech sector.

Comparison to Industry Standards

• Sales by insiders are common across the industry, especially under 10b5-1 plans, which are designed to avoid accusations of trading on non-public information.
• The volume of shares sold by Sheena is significant but not unusual for a founder, especially given the pre-planned nature of the sales.
• Comparable companies often see similar insider transactions, with the market reaction depending on the company's overall performance and outlook.

Stakeholder Impact

• Shareholders may react to the insider selling, potentially leading to short-term price volatility.
• Employees may be concerned about the implications of a co-founder selling shares.

Key Dates

Keywords

Natera, NTRA, insider trading, Form 4, 10b5-1 plan, share sale, Jonathan Sheena, Caraluna Trust